Efficacy and Safety of UGN-101 in Recurrent Patients

Clinical trial NCT04006691 · WITHDRAWN

Trial details

NCT number: NCT04006691
Sponsor: UroGen Pharma Ltd.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma Transitional Cell Carcinoma Transitional Cell Cancer of the Renal Pelvis and Ureter

Start date: 2019-10-01
Primary completion: 2020-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.